Pharmaceutical Care for Patients Using Capecitabine

Clinical trial NCT07063706 · COMPLETED

Trial details

NCT number: NCT07063706
Sponsor: Faculdade de Farmácia
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cancer Colorectal Cancer Gi Capecitabine Pharmaceutical Services Adverse Drug Reaction (ADR)

Start date: 2022-03-01
Primary completion: 2024-03-31
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.